Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2008 Jul;28(4):314-21.
doi: 10.1007/s10875-007-9164-1. Epub 2008 Jan 26.

Cytokine secretion in long-standing diabetes mellitus type 1 and 2: associations with low-grade systemic inflammation

Affiliations

Cytokine secretion in long-standing diabetes mellitus type 1 and 2: associations with low-grade systemic inflammation

Krystallenia I Alexandraki et al. J Clin Immunol. 2008 Jul.

Abstract

Low-grade systemic chronic inflammation is a very well-known feature of diabetes mellitus (DM). The purpose of this study was the assessment of the proinflammatory cytokine secretion profile in long-standing diabetes along with the presence of features of systemic inflammation. Metabolic parameters and serum high-sensitivity C-reactive protein, interleukin-1beta, interleukin-6, and tumor necrosis factor-alpha levels were determined in 20 patients with type 1 DM and 21 patients with type 2 DM and compared to 34 healthy subjects. The number of cytokine-secreting peripheral blood mononuclear cells (PBMCs), before and after mitogenic stimulation, was also determined in the same groups. Adverse lipid profile, higher levels of inflammatory markers, and higher count of cytokine-secreting cells were observed more prevalently in type 2 diabetics than in controls. After stimulation, the increase in number of cytokine-secreting cells was higher in controls. In conclusion, patients with DM have evidence of low-grade inflammation and abnormal PBMC function that could be related to long-term sequelae, the accelerated atherosclerotic process, and the susceptibility to infections.

PubMed Disclaimer

References

    1. Lancet. 1997 Jan 18;349(9046):170-3 - PubMed
    1. Diabetes Care. 1998 Apr;21(4):487-93 - PubMed
    1. Mediators Inflamm. 2006;2006(1):39062 - PubMed
    1. Diabetes Res Clin Pract. 1993 Aug-Sep;21(2-3):87-93 - PubMed
    1. Rev Endocr Metab Disord. 2003 Sep;4(3):291-9 - PubMed

Publication types